INTELLECTUAL PROPERTY

Seven issued U.S. patents in multimodal biometrics.

Global e·dentity™'s vein-matching and multimodal biometric technology is protected by a portfolio of issued U.S. patents, built continuation by continuation since our first filing in 2018.

Issued U.S. Patents

PATENT NO.

ISSUED

DESCRIPTION

US 10,135,822

November 2018

Biometric Authentication of Individuals Utilizing Characteristics of Bone and Blood Vessel Structures — the company's first issued patent.

US 10,547,611

November 26, 2019

Continuation of the original Multimodal Biometric and Digital Identity patent (US 10,135,822).

US 10,721,228

August 3, 2020

Continuation patent covering advanced multimodal biometric identification and health-monitoring technology.

US 10,880,303

December 2020

Real-time outbreak identification via non-invasive internal imaging, for dual biometric authentication and biometric health monitoring.

US 11,277,405

March 15, 2022

Dual Biometric Authentication and Biometric Health Monitoring Using Chemosensory and Internal Imaging Data.

US 11,368,455

June 21, 2022

Multi-dimensional vascular biometric authentication, enabling non-facial identity verification for transportation and security agencies.

US 11,374,929

June 28, 2022

Biometric Authentications for an Augmented Reality or a Virtual Reality Device.

Challenging Weaker Filings

In March and April 2019, Global e·dentity™ filed two third-party review requests with the USPTO opposing published patent applications from Apple Inc. (NASDAQ: AAPL) — application 15/900,905 (published March 14, 2019) and application 16/132,241 (published March 28, 2019) — as part of defending the originality of our own vein-matching claims.

Securing Identity and Value

Identity fraud is a growing cost for institutions worldwide — reporting in 2020 put every $1 of retail fraud at $3.36 in total cost to U.S. retailers. Global e·dentity™'s multimodal biometric patents are built to close that gap, securing identity with matching that can't be lifted from a photograph or a fingerprint left on a doorknob.

PATENT PORTFOLIO

Seven issued U.S. patents, one identity platform.

Contact us to learn how Global e·dentity™'s patented technology can secure your organization's identity, access and health-screening requirements. Systems integrators and government agencies can also read the deployment briefing, which sets out the patent portfolio, the DHS/TSA research agreement and the integration path on one page.

Gen-2 SDK is available for evaluation

For legal, technical and partner teams reviewing Global e·dentity™'s issued patent portfolio.

REQUEST EVALUATION SDK

ABOUT GLOBAL E·DENTITY™

We are continually developing virtually impenetrable, multi-modal, secure identification products to make the world a smarter and safer place – a bold new world that is free of old encumbrances of physical identification.